α-硫辛酸通过激活AMPK/mTOR通路改善2型糖尿病大鼠肝脏病变*

doi:10.12047/j.cjap.6312.2022.098

中国应用生理学杂志 ›› 2022, Vol. 38 ›› Issue (5): 525-529.doi: 10.12047/j.cjap.6312.2022.098

α-硫辛酸通过激活AMPK/mTOR通路改善2型糖尿病大鼠肝脏病变^*

邱轩¹, 于磊², 田思宇³, 陈雅洁⁴, 阎红伶¹, 刘宽芝^1△

1.河北医科大学第三医院内分泌科, 石家庄 050000;
2.衡水市第四人民医院内分泌科, 衡水 053000;
3.河北医科大学研究生学院;
4.河北医科大学第三医院肝胆外科, 石家庄 050000

收稿日期:2022-04-12 修回日期:2022-09-03 出版日期:2022-09-28 发布日期:2023-04-23
通讯作者: ^△Tel: 18533112966; E-mail: liukuanzhi0214@163.com
基金资助:
^*河北省自然科学基金项目(H2020206490),河北省医学科学研究课题计划项目(20190640);河北省政府资助省级临床医学优秀人才项目

α-lipoic acid ameliorates liver injury in rats with type 2 diabetes mellitus via activating AMPK/mTOR pathway

QIU Xuan¹, YU Lei², TIAN Si-yu³, CHEN Ya-jie⁴, YAN Hong-ling¹, LIU Kuan-zhi^1△

1. Department of Endocrinology, the Third Hospital of Hebei Medical University, Shijiazhuang 050000;
2. Department of Endocrinology, No.4 People's Hospital of Hengshui, Hengshui 053000;
3. Graduate School of Hebei Medical University;
4. Department of Hepatobiliary Surgery, Third Hospital of Hebei Medical University, Shijiazhuang 050051, China

Received:2022-04-12 Revised:2022-09-03 Online:2022-09-28 Published:2023-04-23

摘要/Abstract

摘要： 目的: 探讨α-硫辛酸是否通过激活腺苷酸活化蛋白激酶(AMPK)/雷帕霉素靶蛋白(mTOR)通路改善2型糖尿病(T2DM)大鼠肝损伤。方法: 应用高糖高脂饮食联合链脲佐菌素27.5 mg/(kg·d)腹腔注射法制备T2DM大鼠模型。将32只成模大鼠随机分为4组:T2DM组、α-硫辛酸组、Compound C(AMPK抑制剂)组和α-硫辛酸+ Compound C组,每组各8只。另8只健康Sprague-Dawlay(SD)大鼠作为正常对照组。α-硫辛酸注射液 100 mg/(kg·d) 腹腔注射,Compound C 20 mg/(kg·d) 腹腔注射,药物干预共持续8周。检测相关生化指标;计算肝脏质量指数;进行光镜、电镜观察;采用Western blot方法检测大鼠肝脏中AMPK、p-AMPK、mTOR、p-mTOR蛋白的表达水平。结果: 与正常对照组相比,T2DM组大鼠肝脏质量指数、胰岛素抵抗指数、空腹血糖、谷丙转氨酶、谷草转氨酶、γ –谷氨酰转肽酶、甘油三酯水平均升高(P均＜0.05);肝组织结构损伤,脂肪变明显;肝脏组织中p-AMPK表达显著减少(P＜0.05),p-mTOR表达显著增多(P＜0.05)。α-硫辛酸可逆转上述改变,改善大鼠的胰岛素抵抗(P＜0.05),保护肝脏的结构和功能,同时激活肝细胞内的AMPK/mTOR通路(P均＜0.05)。应用Compound C抑制AMPK活性后,α-硫辛酸的上述保护作用受到抑制(P＜0.05)。结论: α-硫辛酸可通过激活AMPK/mTOR信号通路发挥对T2DM大鼠的肝脏保护作用。

关键词: α-硫辛酸, 2型糖尿病, 糖尿病性肝损伤, AMPK/mTOR通路

Abstract: Objective: To investigate the effect of α-lipoic acid in ameliorating liver injury in rats with type 2 diabetes mellitus via activating adenosine 5'-monophosphate-activate protein kinase (AMPK)/mammalian target of rapamycin (mTOR) pathway. Methods: The T2DM rat models were established by feeding with high-fat, high-sucrose diet and intraperitoneal injection of 27.5 mg/(kg·d) streptozotocin. The 32 rats with T2DM were randomly divided into 4 groups: T2DM group, α-lipoic acid group (LA), Compound C group (Comp C, an inhibitor of AMPK) and LA+Comp C group, with 8 rats in each group. Additionally, 8 Sprague-Dawlay (SD) rats without diabetes were set as normal control. The rats received α-lipoic acid at a dosage of 100 mg/(kg·d) or Compound C at a dosage of 20 mg/(kg·d) by intraperitoneal injection for 8 weeks as needed. The levels of relevant biochemical indexes were detected. The weight of liver was recorded to calculate liver weight index (LWI), and the pathological changes of liver tissues were detected by light and electron microscopy. The levels of AMPK, p-AMPK, mTOR, p-mTOR in rat liver were detected by Western blot. Results: Compared with control group, the levels of LWI, homeostasis model assessment of insulin resistance, fasting blood glucose, alanine transaminase, aspartate transaminase, gamma glutamyl transferase and triglyceride in T2DM group were increased significantly (all P＜0.05). The liver tissue lesions were more serious and hepatic steatosis grade was higher. The expression of p-AMPK was decreased (P＜0.05) and the expression of p-mTOR was increased significantly(P＜0.05). α-lipoic acid could reverse the above-mentioned changes, ameliorate insulin resistance (all P＜0.05), protect the structure and function of liver, and activate the AMPK/mTOR pathway (P＜0.05). The protection of α-lipoic acid was weakened by the inhibition of AMPK with Compound C (P＜0.05). Conclusion: α-lipoic acid could protect the liver of rats with T2DM by activating AMPK/mTOR pathway.

Key words: α-lipoic acid, type 2 diabetes mellitus, diabetic liver injury, Adenosine 5'-monophosphate-activate protein kinase (AMPK)/ mammalian target of rapamycin (mTOR) pathway

中图分类号:

R587.1

邱轩, 于磊, 田思宇, 陈雅洁, 阎红伶, 刘宽芝. α-硫辛酸通过激活AMPK/mTOR通路改善2型糖尿病大鼠肝脏病变^*[J]. 中国应用生理学杂志, 2022, 38(5): 525-529.

QIU Xuan, YU Lei, TIAN Si-yu, CHEN Ya-jie, YAN Hong-ling, LIU Kuan-zhi. α-lipoic acid ameliorates liver injury in rats with type 2 diabetes mellitus via activating AMPK/mTOR pathway[J]. CJAP, 2022, 38(5): 525-529.

参考文献

[1] Sun H, Saeedi P, Karuranga S, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045[J]. Diabetes Res Clin Pract, 2022, 183: 109119.
[2] Qian H, Chao X, Williams J, et al. Autophagy in liver diseases: A review[J]. Mol Aspects Med, 2021, 82: 100973.
[3] Targher G, Corey KE, Byrne CD, et al. The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments[J]. Nat Rev Gastroenterol Hepatol, 2021, 18(9): 599-612.
[4] Meng Z, Liu X, Li T, et al. The SGLT2 inhibitor empagliflozin negatively regulates IL-17/IL-23 axis-mediated inflammatory responses in T2DM with NAFLD via the AMPK/mTOR/autophagy pathway[J]. Int Immunopharmacol, 2021, 94: 107492.
[5] Gao C, Fang L, Zhang H, et al. Metformin induces autophagy via the AMPK-mTOR signaling pathway in human hepatocellular carcinoma cells[J]. Cancer Manag Res, 2020, 12: 5803-5811.
[6] Wang Q, Wei S, Zhou S, et al. Hyperglycemia aggravates acute liver injury by promoting liver-resident macrophage NLRP3 inflammasome activation via the inhibition of AMPK/mTOR-mediated autophagy induction[J]. Immunol Cell Biol, 2020, 98(1): 54-66.
[7] Zhu Y, Su Y, Zhang J, et al. Astragaloside IV alleviates liver injury in type 2 diabetes due to promotion of AMPK/mTORmediated autophagy[J]. Mol Med Rep, 2021, 23(6): 437.
[8] Jeon MJ, Kim WG, Lim S, et al. Alpha lipoic acid inhibits proliferation and epithelial mesenchymal transition of thyroid cancer cells[J]. Mol Cell Endocrinol, 2016, 419: 113-123.
[9] 邱轩, 季虹, 陈雅洁, 等. α-硫辛酸通过激活腺苷酸活化蛋白激酶/哺乳动物雷帕霉素靶蛋白通路改善糖尿病肾脏疾病的研究[J]. 中国糖尿病杂志, 2021, 29(12): 916-922.
[10] Qiu X, Liu K, Xiao L, et al. Alpha-lipoic acid regulates the autophagy of vascular smooth muscle cells in diabetes by elevating hydrogen sulfide level[J]. Biochim Biophys Acta Mol Basis Dis, 2018, 1864(11): 3723-3738.
[11] 王天源, 王晓慧. 有氧运动对糖尿病大鼠PPARα信号通路的影响及其与PPARγ关系[J]. 中国应用生理学杂志, 2020, 36(4): 312-317.
[12] Zhong J, Gong W, Lu L, et al. Irbesartan ameliorates hyperlipidemia and liver steatosis in type 2 diabetic db/db mice via stimulating PPAR-γ, AMPK/Akt/mTOR signaling and autophagy[J]. Int Immunopharmacol, 2017, 42: 176-184.
[13] 孙红爽, 乜春城, 李鹏霖, 等. 高脂饲料结合慢性应激致大鼠非酒精性脂肪肝的药物治疗[J]. 中国老年学杂志, 2020, 40(1): 177-181.
[14] 杜斌, 杨志勇, 蔡维维, 等. α-硫辛酸对四氯化碳诱导小鼠肝纤维化的保护作用[J]. 中国老年学杂志, 2017, 37(6): 1320-1322.
[15] 王佳, 王丽萍, 张伟. 硫辛酸灌胃对大鼠肾缺血再灌注后肝损伤的防治作用及机制探讨[J]. 山东医药, 2017, 57(47): 31-34.
[16] Zhou L, Cheng Y. Alpha-lipoic acid alleviated 6-OHDA-induced cell damage by inhibiting AMPK/mTOR mediated autophagy[J]. Neuropharmacology, 2019, 155: 98-103.
[17] Liu G, Kuang S, Cao R, et al. Sorafenib kills liver cancer cells by disrupting SCD1-mediated synthesis of monounsaturated fatty acids via the ATP-AMPK-mTOR-SREBP1 signaling pathway[J]. FASEB J, 2019, 33(9): 10089-10103.
[18] 王锋, 张海峰. 利拉鲁肽联合维生素D对高脂诱导非酒精性脂肪肝小鼠的影响及机制[J]. 中国应用生理学杂志, 2020, 36(3): 261-265.
[19] Gao Y, Zhang W, Zeng LQ, et al. Exercise and dietary intervention ameliorate high-fat diet-induced NAFLD and liver aging by inducing lipophagy[J]. Redox Biol, 2020, 36: 101635.
[20] Liang Y, Zhang Z, Tu J, et al. γ-Linolenic acid prevents lipid metabolism disorder in palmitic acid-treated alpha mouse liver-12 cells by balancing autophagy and apoptosis via the LKB1-AMPK-mTOR pathway[J]. J Agric Food Chem, 2021, 69(29): 8257-8267.
[21] Nasiri-Ansari N, Nikolopoulou C, Papoutsi K, et al. Empagliflozin attenuates non-alcoholic fatty liver disease (NAFLD) in high fat diet fed ApoE((-/-)) mice by activating autophagy and reducing ER stress and apoptosis[J]. Int J Mol Sci, 2021, 22(2).
[22] 桑文华, 曾美纯, 陈莎, 等. 自噬抑制剂氯喹对急性酒精诱导小鼠肝损伤的影响[J]. 中国应用生理学杂志, 2018, 34(2): 102-105.
[23] Shen B, Feng H, Cheng J, et al. Geniposide alleviates non-alcohol fatty liver disease via regulating Nrf2/AMPK/mTOR signalling pathways[J]. J Cell Mol Med, 2020, 24(9): 5097-5108.

α-硫辛酸通过激活AMPK/mTOR通路改善2型糖尿病大鼠肝脏病变^*

α-lipoic acid ameliorates liver injury in rats with type 2 diabetes mellitus via activating AMPK/mTOR pathway

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	陆润兰, 李萍, 李兵, 邢媛, 张媛媛, 陈斌泽, 胡秦妮, 杨志华, 高保东, 哈小琴, 高彩燕. 海拔高度对2型糖尿病患者循环内皮祖细胞及低氧诱导因子的影响^*[J]. 中国应用生理学杂志, 2021, 37(5): 529-533.
[2]	徐云, 陈雪辉, 白立炜, 尹清风, 冯春瑜, 张清贵. 达格列净对2型糖尿病大鼠肾脏葡萄糖转运蛋白2及葡萄糖转运蛋白4基因表达的影响^*[J]. 中国应用生理学杂志, 2020, 36(6): 565-570.
[3]	孙晓娟, 冯武龙, 侯娜, 李娜, 姜蔚丽. 有氧运动和白藜芦醇对2型糖尿病大鼠肾脏JAK2及TGF-β1的影响[J]. 中国应用生理学杂志, 2020, 36(3): 202-206.
[4]	衣雪洁, 孙玉霞, 姚婷婷, 李晶, 高畅, 刘璐, 曹师承, 常波, 张翠萍. 急、慢性运动对2型糖尿病大鼠脂肪PI3K/AKT/GLUT4通路的影响[J]. 中国应用生理学杂志, 2020, 36(1): 12-16.
[5]	白淑芝, 徐娜, 王跃虹, 李鸿珠, 李宏霞. 糖尿病大鼠心肌功能的改变及其机制^*[J]. 中国应用生理学杂志, 2019, 35(5): 390-392.
[6]	项伟玲, 金丽琴, 高峰, 肖敏, 陈燕. 黑苦荞茎叶对2型糖尿病小鼠的治疗作用及其对其胰腺、脾脏的影响^*[J]. 中国应用生理学杂志, 2019, 35(2): 140-144.
[7]	谢克俭, 黄玲, 屈小虎, 李雪, 王少杰, 肖敏. 口服AdipoRon对2型糖尿病小鼠脾脏和胰腺功能的影响[J]. 中国应用生理学杂志, 2019, 35(1): 60-64.
[8]	黄玲, 屈小虎, 陈慧, 谢克俭, 肖敏. AdipoRon对2型糖尿病小鼠肾脏损伤的干预作用[J]. 中国应用生理学杂志, 2018, 34(6): 568-571.
[9]	朱雅冰, 贾改丽, 陆嘉辉, 张茂表, 李军, 曹红. 脊髓自噬功能激活与大鼠2型糖尿病神经病理性疼痛的关系[J]. 中国应用生理学杂志, 2018, 34(4): 318-323.
[10]	王继, 周越, 张荷, 李文博, 黄怡. Myostatin信号通路在4周离心耐力运动改善2型糖尿病大鼠骨骼肌萎缩中的作用[J]. 中国应用生理学杂志, 2018, 34(3): 223-228.
[11]	林小晶, 杨宏芳, 王晓慧. 有氧运动与饮食控制对2型糖尿病大鼠肝chemerin及其受体CMKLR1的影响[J]. 中国应用生理学杂志, 2017, 33(5): 426-430.
[12]	朱责梅, 阳际花, 杨丝丝, 何剑琴, 张恺芳, 奉水东, 凌宏艳. 二氢杨梅素对2型糖尿病小鼠认知功能障碍的影响[J]. 中国应用生理学杂志, 2017, 33(4): 323-328.
[13]	黄俊霞, 陈祖盛, 张阳, 张凯, 陈艳艳, 陈丽敏, 周炜炜. 2型糖尿病伴发高血压大鼠模型的建立[J]. 中国应用生理学杂志, 2017, 33(4): 329-333.
[14]	马益梅, 李传达, 朱雅冰, 徐霞, 李军, 曹红. RvD1对大鼠2型糖尿病神经病理性痛的作用及机制研究[J]. 中国应用生理学杂志, 2017, 33(3): 277-281.
[15]	肖敏, 屈小虎, 陈慧, 蔡强军, 谢克俭. 口服活性AdipoRon对2型糖尿病小鼠肝脏氧化应激的干预作用[J]. 中国应用生理学杂志, 2017, 33(2): 124-127.